PUBLISHER: The Business Research Company | PRODUCT CODE: 1946608
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946608
Next-generation mass spectrometers are advanced analytical instruments engineered to deliver ultra-high sensitivity, resolution, and speed for detecting and quantifying molecules across diverse applications, including proteomics, metabolomics, drug discovery, and environmental analysis. These instruments often incorporate cutting-edge technologies such as artificial intelligence, novel ion optics, and real-time data processing to enhance performance, minimize sample requirements, and provide more precise and comprehensive molecular insights.
The primary types of next-generation mass spectrometers include Fourier transform mass spectrometry, linear ion trap mass spectrometry, and others. Fourier transform mass spectrometry uses a mathematical approach to convert a time-domain signal into its frequency-domain representation, revealing how the signal's energy is distributed across different frequencies. Key applications span pharmaceuticals, biotechnology, clinical diagnostics, environmental analysis, food and beverage testing, forensic science, and more. End users include research laboratories, academic institutions, pharmaceutical companies, biotechnology firms, clinical laboratories, and government agencies.
Tariffs are impacting the next-generation mass spectrometer market by increasing costs of imported precision components, ion optics, and high-resolution sensors. Segments such as ft-ms and linear ion trap mass spectrometers are most impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased instrument pricing and delays in delivery. On the positive side, tariffs are encouraging local manufacturing, investment in domestic R&D, and development of cost-optimized alternatives.
The next-generation mass spectrometer market research report is one of a series of new reports from The Business Research Company that provides next-generation mass spectrometer market statistics, including next-generation mass spectrometer industry global market size, regional shares, competitors with a next-generation mass spectrometer market share, detailed next-generation mass spectrometer market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation mass spectrometer industry. This next-generation mass spectrometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The next-generation mass spectrometer market size has grown rapidly in recent years. It will grow from $3.6 billion in 2025 to $3.96 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to limited sensitivity and resolution of early mass spectrometers, reliance on conventional ion trap and quadrupole systems, growing pharmaceutical and biotech research, increasing demand for accurate molecular analysis, high operational complexity and maintenance costs.
The next-generation mass spectrometer market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to development of next-generation ft-ms and orbitrap systems, integration of ai-based data interpretation, expansion of clinical diagnostics and forensic applications, rising environmental monitoring and food safety testing, demand for high-throughput and automated mass spectrometry systems. Major trends in the forecast period include rising demand for high-resolution mass spectrometry, integration of real-time data processing and analytics, expansion of proteomics and metabolomics research, increased adoption in environmental and food testing applications, focus on miniaturization and enhanced sensitivity of instruments.
The increasing focus on personalized medicine is expected to drive the growth of the next-generation mass spectrometer market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual's unique genetic, environmental, and lifestyle factors to achieve more effective outcomes. The rising emphasis on personalized medicine is driven by the need for tailored therapies that enhance patient outcomes, minimize side effects, and optimize healthcare efficiency according to individual genetic and lifestyle profiles. Next-generation mass spectrometers support personalized medicine by delivering highly precise and comprehensive molecular analyses, enabling the identification of patient-specific biomarkers, monitoring of therapeutic responses, and guidance of individualized treatment plans for improved outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized medicines for rare disease patients, up from six in 2022. Consequently, the growing emphasis on personalized medicine is fueling the growth of the next-generation mass spectrometer market.
Major companies in the next-generation mass spectrometer market are focusing on developing highly efficient instruments that allow researchers to analyze complex biological samples with unprecedented speed and precision. These innovations aim to advance biomarker discovery, enable early disease detection, and accelerate the development of personalized therapies. For example, in June 2023, Thermo Fisher Scientific Inc., a U.S.-based clinical research company, launched the Orbitrap Astral mass spectrometer, representing one of the most significant advancements in mass spectrometry in the past 15 years. This next-generation instrument allows detection of previously inaccessible low-abundance proteins by combining ultra-fast scan speeds, exceptional sensitivity, and deep proteome coverage. It also features enhanced ion transmission efficiency, improved dynamic range, and up to four times higher throughput, facilitating faster biomarker discovery, precise protein quantification, and the development of targeted therapies across a wide range of diseases.
In July 2024, Thermo Fisher Scientific acquired Olink Holdings AB for $3.1 billion. This acquisition integrates Olink's next-generation proteomics solutions into Thermo Fisher's mass spectrometry portfolio, enhancing capabilities in protein analysis, accelerating scientific discovery, and supporting precision medicine initiatives. Olink Holdings AB, based in Sweden, specializes in advanced proteomics solutions for next-generation mass spectrometers.
Major companies operating in the next-generation mass spectrometer market are Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., JEOL Ltd., Rigaku Corporation, LECO Corporation, Hiden Analytical Ltd., Scion Instruments Ltd., MOBILion Systems Inc., Jiangsu Skyray Instrument Co. Ltd., Advion Inc., Postnova Analytics GmbH, Kore Technology Ltd., Variolytics GmbH, Spectroswiss, Excellims Corporation, 908 Devices Inc.
North America was the largest region in the next-generation mass spectrometer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation mass spectrometer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the next-generation mass spectrometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The next-generation mass spectrometer consists of sales of electrospray ionization, atmospheric pressure chemical ionization, trapped ion mobility spectrometry, faraday cups, and photodiode arrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Next-Generation Mass Spectrometer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses next-generation mass spectrometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for next-generation mass spectrometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation mass spectrometer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.